doi: 10.1016/0266-4356(92)90263-i.
Expression of the tumour suppressor gene p53 in oral cancer
Affiliations
- PMID: 1380822
- DOI: 10.1016/0266-4356(92)90263-i
Item in Clipboard
Expression of the tumour suppressor gene p53 in oral cancer
Br J Oral Maxillofac Surg.
1992 Aug.
Abstract
In this preliminary series, the product of the tumour suppressor gene p53 was detected in 12/15 cases of oral squamous cell carcinoma (SCC) and in two cases of leukoplakia. The tumours either expressed the mutant form of p53 throughout the specimen or contained focal areas of positive cells. p53 expression was commonly observed in tumours obtained from patients who were heavy smokers and drinkers suggesting that alterations in the p53 gene may be one of the sites of genetic damage in this group of patients.
Comment in
-
p53 expression in oral disease.Br J Oral Maxillofac Surg. 1993 Feb;31(1):63. doi: 10.1016/0266-4356(93)90106-7. Br J Oral Maxillofac Surg. 1993. PMID: 8431418 No abstract available.
Similar articles
-
Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.Br J Oral Maxillofac Surg. 1998 Aug;36(4):252-60. doi: 10.1016/s0266-4356(98)90708-2. Br J Oral Maxillofac Surg. 1998. PMID: 9762452
-
Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.J Investig Clin Dent. 2014 Aug;5(3):214-9. doi: 10.1111/jicd.12038. Epub 2013 Jun 18. J Investig Clin Dent. 2014. PMID: 23776093
-
Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.Otolaryngol Head Neck Surg. 1994 Dec;111(6):758-63. doi: 10.1177/019459989411100610. Otolaryngol Head Neck Surg. 1994. PMID: 7527509
-
Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions.J Oral Pathol Med. 1992 Oct;21(9):404-8. doi: 10.1111/j.1600-0714.1992.tb01028.x. J Oral Pathol Med. 1992. PMID: 1432735 Review.
-
Progress in determining the malignant potential of oral lesions.J Oral Pathol Med. 2003 May;32(5):251-6. doi: 10.1034/j.1600-0714.2003.00108.x. J Oral Pathol Med. 2003. PMID: 12694347 Review.
Cited by
-
p53, p63 and p73 expression and angiogenesis in keratocystic odontogenic tumors.J Clin Exp Dent. 2016 Dec 1;8(5):e505-e511. doi: 10.4317/jced.52843. eCollection 2016 Dec. J Clin Exp Dent. 2016. PMID: 27957261 Free PMC article.
-
In vivo infiltration of mononuclear cells in squamous cell carcinoma of the head and neck correlates with the ability to expand tumour-infiltrating T cells in vitro and with the expression of MHC class I antigens on tumour cells.Cancer Immunol Immunother. 1994 Dec;39(6):383-90. doi: 10.1007/BF01534425. Cancer Immunol Immunother. 1994. PMID: 8001026 Free PMC article.
-
p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.Br J Cancer. 1995 Apr;71(4):826-30. doi: 10.1038/bjc.1995.159. Br J Cancer. 1995. PMID: 7710950 Free PMC article.
-
Genes and oral cancer.Indian J Hum Genet. 2014 Jan;20(1):4-9. doi: 10.4103/0971-6866.132745. Indian J Hum Genet. 2014. PMID: 24959008 Free PMC article. Review.
-
Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical study.Natl J Maxillofac Surg. 2011 Jan;2(1):38-46. doi: 10.4103/0975-5950.85852. Natl J Maxillofac Surg. 2011. PMID: 22442608 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous